Basic polyamino acids rich in arginine, lysine, or ornithine cause both enhancement of and refractoriness to formation of endothelium-derived nitric oxide in pulmonary artery and vein.
Authors:
- 1 February 1989
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 64 (2) , 315-329
Abstract
The objective of this study was to elucidate the mechanism by which polyamino acids containing L-arginine, L-lysine or L-ornithine cause endothelium-dependent relaxation of bovine intrapulmonary artery and vein. Basic but not acidic or neutral polypeptides ranging in average molecular weights from 17 to 225 kDa elicited time- and concentration-dependent relaxation and cyclic GMP accumulation in precontracted rings of artery and vein by endothelium-dependent mechanisms. Vascular responses were markedly inhibited by oxyhemoglobin, methylene blue, or potassium. The basic polyamino acids stimulated the formation and/or release of an endothelium-derived relaxing factor (EDRF) identified as nitric oxide (NO) in perfused segments of both artery and vein as assessed by bioassay. The polyamino acids and A23187 released a similar endothelium-derived NO (EDNO) from artery and vein, as assessed by the similar half-life (3-5 seconds), antagonism by superoxide anion or oxyhemoglobin, enhancement by superoxide dismutase, and lack of influence by indomethacin. The basic polyamino acids elicited potent relaxant responses with EC50 values ranging from 3 x 10(-9) to 2 x 10(-7) M, and a direct correlation was obtained between molecular weight and relaxation potency irrespective of the basic amino acid incorporated. Prolonged contact of arterial or venous rings with basic polyamino acids resulted in the rapid development of marked refractoriness to relaxation and cyclic GMP formation on addition of polyamino acid. Moreover, refractoriness developed to the vascular responses of other endothelium-dependent vasodilators but not to glyceryl trinitrate or isoproterenol. The mechanism of refractory responses was attributed to interference with EDNO formation and release as assessed by bioassay and chemical assay. The hypothesis is forwarded that the basic polyamino acids serve as partial substrates for the enzyme system that catalyzes the conversion of L-arginine to NO. Prolonged contact between substrate and enzyme results in enzyme desensitization and the development of refractoriness or a form of tolerance to vasodilators whose action is mediated by EDNO.Keywords
This publication has 43 references indexed in Scilit:
- Vascular endothelial cells synthesize nitric oxide from L-arginineNature, 1988
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- Endothelium dependent vascular relaxation by arginine containing polypeptidesBiochemical and Biophysical Research Communications, 1986
- Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factorNature, 1986
- Release and properties of endothelium‐derived relaxing factor (EDRF) from endothelial cells in cultureJournal of Cellular Physiology, 1985
- Vasoactive Intestinal Polypeptide-Like Substance: The Potential Transmitter for Cerebral VasodilationScience, 1984
- The Role of Endothelium in the Responses of Vascular Smooth Muscle to DrugsAnnual Review of Pharmacology and Toxicology, 1984
- Vasoactive intestinal peptide as a neurotransmitter in the cerebral circulationEuropean Journal of Pharmacology, 1982
- Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitriteCanadian Journal of Physiology and Pharmacology, 1981
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980